LTFS
EDSA icon

Ladenburg Thalmann Financial Services’s Edesa Biotech EDSA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$0 Hold
2
– – ﹤0.01% 5361
2019
Q3 		$0 Buy
2
+1
+100% +$36 ﹤0.01% 5314
2019
Q2 		$0 Hold
1
– – ﹤0.01% 5299
2019
Q1 		$0 Hold
1
– – ﹤0.01% 5231
2018
Q4 		$0 Hold
1
– – ﹤0.01% 5232
2018
Q3 		$0 Sell
1
-7
-88% -$446 ﹤0.01% 5183
2018
Q2 		$0 Buy
8
+7
+700% +$1K ﹤0.01% 5109
2018
Q1 		$0 Hold
1
– – ﹤0.01% 5124
2017
Q4 		$0 Sell
1
-1
-50% -$318 ﹤0.01% 5047
2017
Q3 		$1K Hold
2
– – ﹤0.01% 4779
2017
Q2 		$1K Hold
2
– – ﹤0.01% 4717
2017
Q1 		$1K Hold
2
– – ﹤0.01% 4696
2016
Q4 		$1K Hold
2
– – ﹤0.01% 4645
2016
Q3 		$2K Hold
2
– – ﹤0.01% 4466
2016
Q2 		$3K Sell
2
-8
-80% -$8.24K ﹤0.01% 4283
2016
Q1 		$15K Hold
10
– – ﹤0.01% 3441
2015
Q4 		$20K Buy
+10
New +$23.2K ﹤0.01% 3217

Other funds holding EDSA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Ladenburg Thalmann Financial Services's EDSA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Edesa Biotech (EDSA) position steady in Q4 2019 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5361.

Ladenburg Thalmann Financial Services first reported a position in EDSA in Q4 2015 and has held it in 17 quarters since. The position peaked at $20K in Q4 2015. 9 funds tracked by Wall St. Rank hold EDSA as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 2 shares of Edesa Biotech worth $0 as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Edesa Biotech share count unchanged in Q4 2019.
  • Edesa Biotech made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5361 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Edesa Biotech in Q4 2015 and has held it in 17 quarters since.
  • Ladenburg Thalmann Financial Services's Edesa Biotech position peaked at $20K in Q4 2015.
  • 9 funds tracked by Wall St. Rank held Edesa Biotech as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.